Maxcyte (MXCT) Goodwill & Intangibles (2025 - 2026)

Maxcyte (MXCT) reported Goodwill & Intangibles of $783000.0 for Q1 2026, down 83.06% year-over-year from $4.6 million in Q1 2025, and up 20.46% on a QoQ basis from $650000.0 in Q4 2025.

Maxcyte (MXCT) has 2 years of Goodwill & Intangibles data on file, last reported at $783000.0 in Q1 2026.

  • Quarterly Goodwill & Intangibles fell 83.06% year-over-year to $783000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $783000.0 (down 83.06% YoY) and the FY2025 annual result came in at $650000.0, changed N/A from the prior year.
  • Goodwill & Intangibles rose to $783000.0 in Q1 2026 per MXCT's latest filing, from $650000.0 in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $4.6 million in Q1 2025 and bottomed at $650000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Maxcyte 129.85 Mn 129.85 Mn 8.08 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 783,000.00
Dec 31, 2025 650,000.00
Sep 30, 2025 4.22 Mn
Jun 30, 2025 4.39 Mn
Mar 31, 2025 4.62 Mn